Susan S Chiu1, Mike Y W Kwan2, Shuo Feng3, Joshua S C Wong2, Chi-Wai Leung2, Eunice L Y Chan1, Kwok-Hung Chan4, Tak-Keung Ng5, Wing-Kin To6, Benjamin J Cowling3, J S Malik Peiris3,7. 1. Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital and Li Ka Shing Faculty of Medicine, The University of Hong Kong. 2. Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital. 3. WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health. 4. Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong. 5. Department of Pathology, Princess Margaret Hospital. 6. Department of Pathology, Yan Chai Hospital. 7. Center of Influenza Research, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
Abstract
Background: Influenza A(H3N2) viruses circulated for 12 consecutive months in Hong Kong in 2016-2017, peaking in late June and July 2017. The objective of our study was to estimate the effectiveness of influenza vaccination in preventing hospitalizations in children in Hong Kong. Methods: We conducted a test-negative study between 1 September 2016 and 31 August 2017, enrolling children 6 months to 17 years of age hospitalized for an acute respiratory infection. Influenza was diagnosed by PCR on nasopharyngeal aspirates. Results: We enrolled 5514 children, including 3608 children 6 months to 2 years, 1600 children 3-5 years, and 1206 children 6-17 years of age. Influenza-associated hospitalizations occurred throughout the study year but time of vaccination of these children was also wide spread, from September 2016 to May 2017. Influenza vaccine effectiveness (VE) was 39.7% (95% confidence interval [CI], 14.7%-57.3%) against laboratory-confirmed influenza A(H3N2). In analyses stratified by time since vaccination, the VE against influenza A(H3N2) was 52.8% (95% CI, 17.1%-73.2%) within 3 months of vaccination, and 31.2% (95% CI, -6.6% to 55.6%) 4-6 months after vaccination. Conclusions: Influenza vaccination was effective in preventing hospitalizations in children in Hong Kong.
Background: Influenza A(H3N2) viruses circulated for 12 consecutive months in Hong Kong in 2016-2017, peaking in late June and July 2017. The objective of our study was to estimate the effectiveness of influenza vaccination in preventing hospitalizations in children in Hong Kong. Methods: We conducted a test-negative study between 1 September 2016 and 31 August 2017, enrolling children 6 months to 17 years of age hospitalized for an acute respiratory infection. Influenza was diagnosed by PCR on nasopharyngeal aspirates. Results: We enrolled 5514 children, including 3608 children 6 months to 2 years, 1600 children 3-5 years, and 1206 children 6-17 years of age. Influenza-associated hospitalizations occurred throughout the study year but time of vaccination of these children was also wide spread, from September 2016 to May 2017. Influenza vaccine effectiveness (VE) was 39.7% (95% confidence interval [CI], 14.7%-57.3%) against laboratory-confirmed influenza A(H3N2). In analyses stratified by time since vaccination, the VE against influenza A(H3N2) was 52.8% (95% CI, 17.1%-73.2%) within 3 months of vaccination, and 31.2% (95% CI, -6.6% to 55.6%) 4-6 months after vaccination. Conclusions: Influenza vaccination was effective in preventing hospitalizations in children in Hong Kong.
Authors: Jill M Ferdinands; Alicia M Fry; Sue Reynolds; Joshua Petrie; Brendan Flannery; Michael L Jackson; Edward A Belongia Journal: Clin Infect Dis Date: 2016-12-29 Impact factor: 9.079
Authors: Edward A Belongia; Melissa D Simpson; Jennifer P King; Maria E Sundaram; Nicholas S Kelley; Michael T Osterholm; Huong Q McLean Journal: Lancet Infect Dis Date: 2016-04-06 Impact factor: 25.071
Authors: Susan S Chiu; Shuo Feng; Kwok-Hung Chan; Janice Y C Lo; Eunice L Y Chan; Lok-Yee So; Benjamin J Cowling; J S Malik Peiris Journal: Vaccine Date: 2016-03-21 Impact factor: 3.641
Authors: Danuta M Skowronski; Catharine Chambers; Suzana Sabaiduc; James A Dickinson; Anne-Luise Winter; Gaston De Serres; Steven J Drews; Agatha Jassem; Jonathan B Gubbay; Hugues Charest; Robert Balshaw; Nathalie Bastien; Yan Li; Mel Krajden Journal: Euro Surveill Date: 2017-02-09
Authors: Lisa A Grohskopf; Leslie Z Sokolow; Sonja J Olsen; Joseph S Bresee; Karen R Broder; Ruth A Karron Journal: MMWR Morb Mortal Wkly Rep Date: 2015-08-07 Impact factor: 17.586
Authors: Shuo Feng; Susan S Chiu; Eunice L Y Chan; Mike Y W Kwan; Joshua S C Wong; Chi-Wai Leung; Yiu Chung Lau; Sheena G Sullivan; J S Malik Peiris; Benjamin J Cowling Journal: Lancet Respir Med Date: 2018-11-12 Impact factor: 30.700
Authors: Huiying Chua; Susan S Chiu; Eunice L Y Chan; Shuo Feng; Mike Y W Kwan; Joshua S C Wong; J S Malik Peiris; Benjamin J Cowling Journal: J Infect Dis Date: 2019-10-08 Impact factor: 5.226
Authors: Huiying Chua; Shuo Feng; Joseph A Lewnard; Sheena G Sullivan; Christopher C Blyth; Marc Lipsitch; Benjamin J Cowling Journal: Epidemiology Date: 2020-01 Impact factor: 4.822
Authors: Susan S Chiu; Mike Yw Kwan; Shuo Feng; Eunice Ly Chan; Huiying Chua; Joshua Sc Wong; Js Malik Peiris; Benjamin J Cowling Journal: Euro Surveill Date: 2019-01
Authors: Winnie W Y Tso; Mike Y W Kwan; Yu Liang Wang; Lok Kan Leung; Daniel Leung; Gilbert T Chua; Patrick Ip; Daniel Y T Fong; Wilfred H S Wong; Sophelia H S Chan; Jasper F W Chan; Malik Peiris; Yu Lung Lau; Jaime S Rosa Duque Journal: Emerg Microbes Infect Date: 2022-12 Impact factor: 19.568